These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1183243)

  • 21. Phenotypes of resistance to fluorophyrimidines and the occurence of 5-fluorocytosine resistant mutants in Candida and Torulopsis yeasts.
    Pawlik B; Barylak J
    Mykosen; 1978 Nov; 21(11):377-81. PubMed ID: 570245
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Normark S; Schönebeck J
    Antimicrob Agents Chemother; 1972 Sep; 2(3):114-21. PubMed ID: 4597703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental infection by Candida krusei (Cast.) Berkhout isolated from a case of corneal ulcer and its sensitivity to antimycotics.
    Tandon RN; Wahab S; Srivastava OP
    Mykosen; 1984 Jul; 27(7):355-60. PubMed ID: 6482899
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M; Winblad B; Anséhn S; Schönebeck J
    Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The study of urinary tract infection with a possible cause of fungi and evaluation of the efficacy of 5-FC].
    Suzuki K; Tamai H
    Hinyokika Kiyo; 1985 Oct; 31(10):1885-94. PubMed ID: 3911766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of flucytosine in patients with urinary fungal infections].
    Tokunaga S; Ohkawa M; Nakashima T; Yamaguchi K; Nishikawa T; Matsushita T; Mikawa I; Hirano S; Kawaguchi S; Miyagi T
    Jpn J Antibiot; 1992 Aug; 45(8):1060-4. PubMed ID: 1433895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yeasts in banal external ocular inflammations.
    Romano A; Segal E; Stein R; Eylan E
    Ophthalmologica; 1975; 170(1):13-21. PubMed ID: 1096003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of antifungal activity of standardized extract of Salvia rhytidea Benth. (Lamiaceae) against various Candida isolates.
    Salari S; Bakhshi T; Sharififar F; Naseri A; Ghasemi Nejad Almani P
    J Mycol Med; 2016 Dec; 26(4):323-330. PubMed ID: 27499461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
    J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
    St-Germain G; Laverdière M; Pelletier R; Bourgault AM; Libman M; Lemieux C; Noël G
    J Clin Microbiol; 2001 Mar; 39(3):949-53. PubMed ID: 11230409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular infections caused by Candida species: Type of species, in vitro susceptibility and treatment outcome.
    Motukupally SR; Nanapur VR; Chathoth KN; Murthy SI; Pappuru RR; Mallick A; Sharma S
    Indian J Med Microbiol; 2015; 33(4):538-46. PubMed ID: 26470961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental intravitreal 5-fluorocytosine.
    Yoshizumi MO; Silverman C
    Ann Ophthalmol; 1985 Jan; 17(1):58-61. PubMed ID: 3977219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species.
    Sóczó G; Kardos G; McNicholas PM; Balogh E; Gergely L; Varga I; Kelentey B; Majoros L
    J Antimicrob Chemother; 2007 Nov; 60(5):1004-9. PubMed ID: 17875607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of fungal infections with flucytosine.
    Harder EJ; Hermans PE
    Arch Intern Med; 1975 Feb; 135(2):231-7. PubMed ID: 1096840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
    Rukayadi Y; Yong D; Hwang JK
    J Antimicrob Chemother; 2006 Jun; 57(6):1231-4. PubMed ID: 16617064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A
    Chemotherapy; 1978; 24(1):2-16. PubMed ID: 338264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.